William Krivit
About
In The Last Decade
William Krivit
55 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 101
- Hematology 537
- Physiology 488
- Molecular Biology 318
- Public Health, Environmental and Occupational Health 275
- Genetics 241
Countries citing papers authored by William Krivit
This map shows the geographic impact of William Krivit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Krivit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Krivit more than expected).
Fields of papers citing papers by William Krivit
This network shows the impact of papers produced by William Krivit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Krivit. The network helps show where William Krivit may publish in the future.
Co-authorship network of co-authors of William Krivit
This figure shows the co-authorship network connecting the top 25 collaborators of William Krivit. A scholar is included among the top collaborators of William Krivit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Krivit. William Krivit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 220 | |
| 2 | 77 | |
| 3 | 19 | |
| 4 | Allogeneic bone marrow transplantation for Niemann-Pick disease (type IA). | 6 |
| 5 | Bone marrow transplantation in metachromatic leukodystrophy. | 16 |
| 6 | 2 | |
| 7 | Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation. | 59 |
| 8 | 'Pseudolymphoma'. A case associated with primary immunodeficiency disease and polyglandular failure syndrome. | 51 |
| 9 | 58 | |
| 10 | 5 | |
| 11 | Hematological aspects of vitamin E. | 0 |
| 12 | 18 | |
| 13 | Enzyme therapy in Fabry's disease by renal transplantation. | 1 |
| 14 | Further observations on the role of the adenyl cyclase-cyclic AMP (CAMP) system in human lipolysis. | 13 |
| 15 | 3 | |
| 16 | Kaolin partial thromboplastin time: high levels of procoagulants producing short clotting times or masking deficiencies of other procoagulants or low concentrations of anticoagulants. | 52 |
| 17 | 7 | |
| 18 | 14 | |
| 19 | 61 | |
| 20 | Studies in disorders of muscle. IX. Glycogen storage disease primarily affecting skeletal muscle and clinically resembling amyotonia congenita. | 31 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.